NKGen Offering Wednesday, September 2, 2026 0.00 Neutral

NKGen Biotech Amends Secured Convertible Loan Agreement with AlpineBrook

NKGen Biotech announced a Fourth Amendment to its Secured Convertible Loan Agreement, increasing the loan amount to $1,050,500 and increasing the number of new consideration shares.

View original filing at SEC.gov →

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day